Structures by: Florence A. J.
Total: 219
Olanzapine 1,2-dimethoxyethane hydrate
(C17H20N4s1),0.5(C4H10O2),(H2O)
Crystal Growth & Design (2013) 13, 4 1602
a=24.4675(13)Å b=12.2298(8)Å c=15.1073(8)Å
α=90.00° β=125.675(2)° γ=90.00°
Olanzapine methanol
C17H20N4S1(C1H4O1)
Crystal Growth & Design (2013) 13, 4 1602
a=10.1493(9)Å b=12.2895(10)Å c=14.0944(13)Å
α=90.00° β=91.905(5)° γ=90.00°
Olanzapine dihydrate
C17H20N4S1,2(H2O1)
Crystal Growth & Design (2013) 13, 4 1602
a=9.846(2)Å b=12.672(3)Å c=14.384(3)Å
α=90.00° β=92.724(9)° γ=90.00°
Olanzapine dichloromethane
2(C17H20N4S1),1(CH2Cl2)
Crystal Growth & Design (2013) 13, 4 1602
a=9.6671(15)Å b=11.5070(17)Å c=16.697(2)Å
α=103.991(6)° β=96.989(6)° γ=99.825(6)°
Olanzapine 1,4-dioxan hydrate
C17H20N4S,0.5(C4H8O2),(H2O1)
Crystal Growth & Design (2013) 13, 4 1602
a=24.447(3)Å b=12.5660(16)Å c=14.9591(19)Å
α=90.00° β=125.421(5)° γ=90.00°
Olanzapine acetonitrile hydrate
(C17H20N4S1),(C2H3N1),(H2O)
Crystal Growth & Design (2013) 13, 4 1602
a=24.381(2)Å b=12.3856(9)Å c=15.0565(14)Å
α=90.00° β=125.321(7)° γ=90.00°
Olanzpaine tetrahydrofuran hydrate
C17H20N4S,0.5(C4H8O),(H2O)
Crystal Growth & Design (2013) 13, 4 1602
a=24.2355(10)Å b=12.5913(5)Å c=15.0767(6)Å
α=90.00° β=124.9990(10)° γ=90.00°
Olanzapine acetone hydrate
C17H20N4S1,0.5(C3O1H6),(H2O1)
Crystal Growth & Design (2013) 13, 4 1602
a=24.226(2)Å b=12.5269(12)Å c=15.0737(15)Å
α=90.00° β=124.976(4)° γ=90.00°
Olanzapine methylacetate hydrate
C17H20N4S1,0.5(C3H6O2),H2O1
Crystal Growth & Design (2013) 13, 4 1602
a=24.899(4)Å b=12.5316(19)Å c=15.243(2)Å
α=90.00° β=126.990(5)° γ=90.00°
Olanzapine 1,2 propanediol hydrate
C17H20N4S1,(C3H8O2),(H2O)
Crystal Growth & Design (2013) 13, 4 1602
a=24.704(2)Å b=12.1883(10)Å c=15.1242(12)Å
α=90.00° β=125.206(3)° γ=90.00°
Olanzapine 1-propanol hydrate
C17H20N4S1,0.5(C3H8O1),(H2O1)
Crystal Growth & Design (2013) 13, 4 1602
a=24.4748(13)Å b=12.3515(6)Å c=15.1109(8)Å
α=90.00° β=125.6490(10)° γ=90.00°
Olanzapine higher hydrate
C17H20N4S1,2.5(H2O1)
Crystal Growth & Design (2013) 13, 4 1602
a=24.940(6)Å b=12.156(3)Å c=14.867(3)Å
α=90.00° β=124.928(6)° γ=90.00°
1,3,5-trihydroxybenzene
C6H6O3
Crystal growth & design (2013) 13, 9 4071-4083
a=12.1207(6)Å b=3.80651(13)Å c=13.1647(6)Å
α=90° β=115.478(6)° γ=90°
Pyrogallol_tetartohydrate
4(C6H6O3),H2O
Crystal growth & design (2013) 13, 9 4071-4083
a=24.6058(6)Å b=24.6058(6)Å c=3.8524(3)Å
α=90° β=90° γ=90°
C49H51N3O26Zn4,H2O,3(O)
C49H51N3O26Zn4,H2O,3(O)
Chemical communications (Cambridge, England) (2007) 15 1532-1534
a=13.0757(6)Å b=14.1157(7)Å c=16.6631(8)Å
α=66.6020(10)° β=87.1380(10)° γ=89.7570(10)°
C48H66N4O5
C48H66N4O5
Crystal Growth & Design (2014) 14, 5 2422
a=9.7937(3)Å b=15.2747(5)Å c=31.0802(10)Å
α=90.00° β=98.472(3)° γ=90.00°
Remacemide hydrochloride salt
C17H21N2O,Cl
Crystal Growth & Design (2005) 5, 2 427
a=10.660(2)Å b=8.712(2)Å c=17.624(3)Å
α=90.00° β=90.770(18)° γ=90.00°
Olanzapine pyridine hydrate
2(C17H20N4S1),(C5H5N)2(H2O)
Crystal Growth & Design (2013) 13, 4 1602
a=14.8824(7)Å b=12.7289(7)Å c=20.3218(11)Å
α=90.00° β=93.465(2)° γ=90.00°
C13H18O2
C13H18O2
Chemical Communications (1996) 7 855-856
a=14.397(8)Å b=7.818(4)Å c=10.506(6)Å
α=90° β=99.70(3)° γ=90°